{"title":"印度特里凡得琅三级医院哮喘患者的支气管扩张剂可逆性","authors":"S. Nair, P. Arjun","doi":"10.1183/13993003.congress-2019.pa715","DOIUrl":null,"url":null,"abstract":"Introduction: Demonstration of post-bronchodilator reversibility is considered as an important tool for the diagnosis of Asthma, however this is not demonstrable in all patients. Aims and Objectives: To determine the proportion of patients with Asthma presenting to tertiary care hospital in Trivandrum, South India who show post-bronchodilator reversibility on spirometry and to determine the factors associated with reversibility Methods: Consecutive patients with clinician diagnosed asthma (by a senior pulmonologist, based on GINA guidelines) underwent spirometry as part of their diagnostic work-up at the time of their presentation in two tertiary care hospitals. Pre- and post bronchodilator spirometry were done by an expert technician. Reversibility was defined as increase in FEV1 by 200ml and 12% Results: 200 consecutive patients with Asthma were recruited. Mean age of the patients was 41.5 years (SD - 18.2). 59.5% of the patients were femaies. The proportion of patients with reversibility was 47% (95%CI-40%,54%). The factors associated with reversibility were low age( 0.05). Conclusion: While developing local guidelines for diagnosis of Asthma, the fact that reversibility can be demonstrated only less than 50% of patients must be considered, otherwise a significant proportion of cases with Asthma may be missed or misdiagnosed as COPD.","PeriodicalId":432006,"journal":{"name":"General practice and primary care","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bronchodilator reversibility among patients with asthma presenting to tertiary care hospitals in Trivandrum, India\",\"authors\":\"S. Nair, P. Arjun\",\"doi\":\"10.1183/13993003.congress-2019.pa715\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Demonstration of post-bronchodilator reversibility is considered as an important tool for the diagnosis of Asthma, however this is not demonstrable in all patients. Aims and Objectives: To determine the proportion of patients with Asthma presenting to tertiary care hospital in Trivandrum, South India who show post-bronchodilator reversibility on spirometry and to determine the factors associated with reversibility Methods: Consecutive patients with clinician diagnosed asthma (by a senior pulmonologist, based on GINA guidelines) underwent spirometry as part of their diagnostic work-up at the time of their presentation in two tertiary care hospitals. Pre- and post bronchodilator spirometry were done by an expert technician. Reversibility was defined as increase in FEV1 by 200ml and 12% Results: 200 consecutive patients with Asthma were recruited. Mean age of the patients was 41.5 years (SD - 18.2). 59.5% of the patients were femaies. The proportion of patients with reversibility was 47% (95%CI-40%,54%). The factors associated with reversibility were low age( 0.05). Conclusion: While developing local guidelines for diagnosis of Asthma, the fact that reversibility can be demonstrated only less than 50% of patients must be considered, otherwise a significant proportion of cases with Asthma may be missed or misdiagnosed as COPD.\",\"PeriodicalId\":432006,\"journal\":{\"name\":\"General practice and primary care\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-09-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"General practice and primary care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1183/13993003.congress-2019.pa715\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"General practice and primary care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2019.pa715","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Bronchodilator reversibility among patients with asthma presenting to tertiary care hospitals in Trivandrum, India
Introduction: Demonstration of post-bronchodilator reversibility is considered as an important tool for the diagnosis of Asthma, however this is not demonstrable in all patients. Aims and Objectives: To determine the proportion of patients with Asthma presenting to tertiary care hospital in Trivandrum, South India who show post-bronchodilator reversibility on spirometry and to determine the factors associated with reversibility Methods: Consecutive patients with clinician diagnosed asthma (by a senior pulmonologist, based on GINA guidelines) underwent spirometry as part of their diagnostic work-up at the time of their presentation in two tertiary care hospitals. Pre- and post bronchodilator spirometry were done by an expert technician. Reversibility was defined as increase in FEV1 by 200ml and 12% Results: 200 consecutive patients with Asthma were recruited. Mean age of the patients was 41.5 years (SD - 18.2). 59.5% of the patients were femaies. The proportion of patients with reversibility was 47% (95%CI-40%,54%). The factors associated with reversibility were low age( 0.05). Conclusion: While developing local guidelines for diagnosis of Asthma, the fact that reversibility can be demonstrated only less than 50% of patients must be considered, otherwise a significant proportion of cases with Asthma may be missed or misdiagnosed as COPD.